Parasol Med Tech discloses $2.365M sold for gel-based heart device
Parasol Med Tech has sold 94.6% of its $2.5M offering target for a patient-specific gel seal competing with Watchman and Amulet.
By RuntimeWire Staff · Published
Primary source: U.S. Securities and Exchange Commission
Why it matters
Parasol is turning a practicing cardiologist's procedural experience into a personalized implant, with enough capital to pursue prototype and preclinical proof points.
Dr. Atman Shah's Parasol Med Tech has sold $2.365 million of a planned $2.5 million equity offering, according to a Form D filed with the SEC on September 10th. The filing lists 29 investors and $135,000 remaining in the round.…